CN103656566B - A kind of Chinese medicine composition for the treatment of cirrhotic ascites - Google Patents
A kind of Chinese medicine composition for the treatment of cirrhotic ascites Download PDFInfo
- Publication number
- CN103656566B CN103656566B CN201310583945.6A CN201310583945A CN103656566B CN 103656566 B CN103656566 B CN 103656566B CN 201310583945 A CN201310583945 A CN 201310583945A CN 103656566 B CN103656566 B CN 103656566B
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- medicine composition
- treatment
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 26
- 206010003445 Ascites Diseases 0.000 title claims abstract description 17
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- 210000000582 semen Anatomy 0.000 claims abstract description 12
- 241000208340 Araliaceae Species 0.000 claims abstract description 6
- 241000255789 Bombyx mori Species 0.000 claims abstract description 6
- 241001057584 Myrrha Species 0.000 claims abstract description 6
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 6
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 6
- 239000010135 fructus aurantii immaturus Substances 0.000 claims abstract description 6
- 235000008434 ginseng Nutrition 0.000 claims abstract description 6
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000004577 thatch Substances 0.000 claims abstract description 6
- 229940079593 drug Drugs 0.000 claims abstract description 5
- 230000001225 therapeutic effect Effects 0.000 abstract description 4
- 206010030113 Oedema Diseases 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 208000002672 hepatitis B Diseases 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 241000521257 Hydrops Species 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241001400084 Anthephora pubescens Species 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010018092 Generalised oedema Diseases 0.000 description 1
- 208000034767 Hypoproteinaemia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010041277 Sodium retention Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000024783 anasarca Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000018191 liver inflammation Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000007232 portal hypertension Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine composition for the treatment of cirrhotic ascites to be made up of the crude drug of following weight portion: silkworm excrement 14-16, Fructus Amomi 14-16, Myrrha 14-16, Radix Paeoniae Alba 28-32, Carapax Trionycis 16-19, Fructus Aurantii Immaturus 28-32, Radix Notoginseng 14-16, Semen Platycladi 14-16, Semen Ziziphi Spinosae 14-16, Poria 14-16, Herba Taraxaci 14-16, Cortex Magnoliae Officinalis 14-16, Radix Linderae 14-16, Radix Platycodonis 14-16, Radix Ginseng 28-32, stir-fry thatch art 14-16, Rhizoma Imperatae 14-16, Rhizoma Zingiberis Recens 14-16, Herba Hedyotidis Diffusae 14-16, Rhizoma Paridis 11-13, Ramulus Mori 28-32.Decoction is cooked into decocting, for oral administration.It is short that this Chinese medicine composition has treatment cycle, therapeutic effect outstanding feature, and relapse rate is low.
Description
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to a kind of Chinese medicine composition for the treatment of cirrhotic ascites.
Background technology
Cirrhotic ascites refers to because hepatic disease causes liver inflammation repeatedly, due to multiple pathological factor after fibrosis and liver cirrhosis are formed, as portal hypertension, hypoproteinemia, water-sodium retention etc. cause the clinical symptoms of intraperitoneal hydrops.The medicine for the treatment of cirrhotic ascites is main mainly with Western medicine, and Western medicine side effect is large, and injure liver further, and therapeutic effect is bad, relapse rate is high.
Summary of the invention
The invention discloses a kind of Chinese medicine composition for the treatment of cirrhotic ascites, it is short that this Chinese medicine composition has treatment cycle, the feature that therapeutic effect is remarkable, relapse rate is low.
The technical solution used in the present invention is as follows:
Treat a Chinese medicine composition for cirrhotic ascites, it is characterized in that, be made up of the crude drug of following weight portion:
Silkworm excrement 14-16, Fructus Amomi 14-16, Myrrha 14-16, Radix Paeoniae Alba 28-32, Carapax Trionycis 16-19, Fructus Aurantii Immaturus 28-32, Radix Notoginseng 14-16, Semen Platycladi 14-16, Semen Ziziphi Spinosae 14-16, Poria 14-16, Herba Taraxaci 14-16, Cortex Magnoliae Officinalis 14-16, Radix Linderae 14-16, Radix Platycodonis 14-16, Radix Ginseng 28-32, stir-fry thatch art 14-16, Rhizoma Imperatae 14-16, Rhizoma Zingiberis Recens 14-16, Herba Hedyotidis Diffusae 14-16, Rhizoma Paridis 11-13, Ramulus Mori 28-32.
The Chinese medicine composition of described treatment cirrhotic ascites, is characterized in that, is made up of the crude drug of following weight portion:
Silkworm excrement 15, Fructus Amomi 15, Myrrha 15, the Radix Paeoniae Alba 30, Carapax Trionycis 18, Fructus Aurantii Immaturus 30, Radix Notoginseng 15, Semen Platycladi 15, Semen Ziziphi Spinosae 15, Poria 15, Herba Taraxaci 15, Cortex Magnoliae Officinalis 15, the Radix Linderae 15, Radix Platycodonis 15, Radix Ginseng 30, stir-fry thatch art 15, Rhizoma Imperatae 15, Rhizoma Zingiberis Recens 15, Herba Hedyotidis Diffusae 15, Rhizoma Paridis 12, Ramulus Mori 30.
Preparation method and consumption: be decocted in water for oral dose, every day 1 dose, take 2 day.Be a course for the treatment of with 30 days, after often taking 1 course for the treatment of, drug withdrawal takes for 10 days again.General initial stage of cancer patient takes a course for the treatment of and can cure, and mid-term, needs of patients took 2-3 the course for the treatment of, and cure rate can reach 90.
Chinese medicine composition of the present invention has liver-smoothing, qi-regulating, benefiting QI and nourishing blood, effect of soft liver easing the affected liver, diuretic, and with this traditional Chinese medicine composition for treating cirrhotic ascites, good effect, instant effect, therapeutic effect is remarkable, cure rate can reach more than 92%.
Detailed description of the invention
(g) takes silkworm excrement 15, Fructus Amomi 15, Myrrha 15, the Radix Paeoniae Alba 30, Carapax Trionycis 18, Fructus Aurantii Immaturus 30, Radix Notoginseng 15, Semen Platycladi 15, Semen Ziziphi Spinosae 15, Poria 15, Herba Taraxaci 15, Cortex Magnoliae Officinalis 15, the Radix Linderae 15, Radix Platycodonis 15, Radix Ginseng 30, fries thatch art 15, Rhizoma Imperatae 15, Rhizoma Zingiberis Recens 15, Herba Hedyotidis Diffusae 15, Rhizoma Paridis 12, Ramulus Mori 30 by weight, with soak by water, successively decoct twice, the medicinal liquid of twice is merged, 100ml altogether, taking at twice, was a course for the treatment of with 1 month, can take 1-3 the course for the treatment of.
model case
Wool grass female 34 years old, suffer from chronic hepatitis B for many years, be converted into cirrhotic ascites afterwards, local county hospital hospitalization 2 months, take a turn for the better to some extent, after leaving hospital latter three months, whole body is edema again, a large amount of hydrops is had again in abdomen, again be in hospital, treat January, do not feel any better, take Chinese medicine composition of the present invention after being introduced, illustratively take, after the course for the treatment of, edema disappears, ascites is all discharged, take medicine again 2 courses for the treatment of, physical recovery is the same with Healthy People, appetite is normal, all are as health, added again a course for the treatment of afterwards, health recovers normal completely, hospital is gone to recheck, recovery from illness, so far do not recur.
Thank to certain man 45 years old, suffer from hepatitis B for many years, because of eating and drinking without temperance system, hepatitis increases the weight of, after be converted into cirrhotic ascites, there is anasarca, a large amount of hydrops in abdomen, hospitalization 2 months, effect is bad, take Chinese medicine composition of the present invention after being introduced, illustratively take, after the course for the treatment of, edema disappears, ascites is all discharged, take medicine 2 courses for the treatment of, physical recovery is the same with Healthy People, and appetite is normal again, all are as health, added again a course for the treatment of afterwards, health recovers normal completely, goes to hospital to recheck, recovery from illness, does not recur so far.
Fourth 42 years old, suffers from hepatitis B for many years, often needs dinner party, drink uncontrolled on working, hepatitis B increases the weight of, and Multiple Hospitalization is treated, and effect is not fine, always often recurs, recommend by people, start to take Chinese medicine composition of the present invention, illustratively take, after the course for the treatment of, edema disappears, and ascites is all discharged, continual cure 2 months, and indices recovers normal, remove examination in hospital, hepatitis is fully recovered, after 4 months, with examining, all are normal, do not recur so far.
Claims (2)
1. treat a Chinese medicine composition for cirrhotic ascites, it is characterized in that, be made up of the crude drug of following weight portion:
Silkworm excrement 14-16, Fructus Amomi 14-16, Myrrha 14-16, Radix Paeoniae Alba 28-32, Carapax Trionycis 16-19, Fructus Aurantii Immaturus 28-32, Radix Notoginseng 14-16, Semen Platycladi 14-16, Semen Ziziphi Spinosae 14-16, Poria 14-16, Herba Taraxaci 14-16, Cortex Magnoliae Officinalis 14-16, Radix Linderae 14-16, Radix Platycodonis 14-16, Radix Ginseng 28-32, stir-fry thatch art 14-16, Rhizoma Imperatae 14-16, Rhizoma Zingiberis Recens 14-16, Herba Hedyotidis Diffusae 14-16, Rhizoma Paridis 11-13, Ramulus Mori 28-32.
2. the Chinese medicine composition for the treatment of cirrhotic ascites according to claim 1, is characterized in that, is made up of the crude drug of following weight portion:
Silkworm excrement 15, Fructus Amomi 15, Myrrha 15, the Radix Paeoniae Alba 30, Carapax Trionycis 18, Fructus Aurantii Immaturus 30, Radix Notoginseng 15, Semen Platycladi 15, Semen Ziziphi Spinosae 15, Poria 15, Herba Taraxaci 15, Cortex Magnoliae Officinalis 15, the Radix Linderae 15, Radix Platycodonis 15, Radix Ginseng 30, stir-fry thatch art 15, Rhizoma Imperatae 15, Rhizoma Zingiberis Recens 15, Herba Hedyotidis Diffusae 15, Rhizoma Paridis 12, Ramulus Mori 30.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310583945.6A CN103656566B (en) | 2013-11-20 | 2013-11-20 | A kind of Chinese medicine composition for the treatment of cirrhotic ascites |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310583945.6A CN103656566B (en) | 2013-11-20 | 2013-11-20 | A kind of Chinese medicine composition for the treatment of cirrhotic ascites |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103656566A CN103656566A (en) | 2014-03-26 |
| CN103656566B true CN103656566B (en) | 2016-04-20 |
Family
ID=50296124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310583945.6A Active CN103656566B (en) | 2013-11-20 | 2013-11-20 | A kind of Chinese medicine composition for the treatment of cirrhotic ascites |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103656566B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102406909A (en) * | 2011-11-09 | 2012-04-11 | 徐天英 | Traditional Chinese medicine formula for treating ascites due to cirrhosis |
-
2013
- 2013-11-20 CN CN201310583945.6A patent/CN103656566B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102406909A (en) * | 2011-11-09 | 2012-04-11 | 徐天英 | Traditional Chinese medicine formula for treating ascites due to cirrhosis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103656566A (en) | 2014-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103432545B (en) | A kind of medicine for pediatrics febricide and preparation method thereof | |
| CN101129496A (en) | Traditional Chinese medicine for treating intractable headache | |
| CN101612329A (en) | Traditional Chinese medicine for treating glomerulonephritis | |
| CN101214304A (en) | Chinese medicine prescription for treating chronic cholecystitis | |
| CN105012735B (en) | One kind fills blood anticancer traditional Chinese medicinal composition | |
| CN103479835A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
| CN103656566B (en) | A kind of Chinese medicine composition for the treatment of cirrhotic ascites | |
| CN103550679A (en) | Traditional Chinese medicine formula for treatment of lithangiuria | |
| CN103071079B (en) | Traditional Chinese medicinal composition for treating prurigo nodularis | |
| CN101502597B (en) | Medicament for treating stomachache and preparation method thereof | |
| CN105456924A (en) | Traditional Chinese medicine preparation containing Folium Artemisiae Argyi and having functions of promoting circulation and removing stasis and preparation method thereof | |
| CN104162043A (en) | Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis | |
| CN103656516A (en) | Chinese herbal preparation for treating diabetic nephropathy | |
| CN103263562A (en) | Traditional Chinese medicine for treating Qi deficiency type constipation | |
| CN103316235B (en) | Traditional Chinese medicine used for treating asthma, and preparation method thereof | |
| CN102908544B (en) | Traditional Chinese medicine decoction for treating coronary disease and preparation method thereof | |
| CN101884714B (en) | Chinese medicinal decoction for treating urticaria | |
| CN100998720B (en) | Oral traditional Chinese medicine for treating amenorrhea of uterus stasis | |
| CN102233004B (en) | Drug for treating liver diseases | |
| CN101152330A (en) | Traditional Chinese medicine for treating hysteria attack | |
| CN103751469A (en) | Composition for treating qi and blood stasis type systemic scleroderma | |
| CN105106385A (en) | Traditional Chinese medicine decoction for treating viral hepatitis | |
| CN104162104A (en) | Medicine for treating chronic atrophic gastritis | |
| CN104138545A (en) | Medicine used for treating eczema | |
| CN104338109A (en) | Traditional Chinese medicine for treating chronic gastritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200423 Address after: 102200 Room 204, floor 104, floor 1-4, building 2, Tiantong Xiyuan District 3, Dongxiaokou Town, Changping District, Beijing Patentee after: Beijing Gulou Research Institute of difficult diseases Co., Ltd Address before: 236500 Anhui city of Fuyang Province Jieshou City Shu Zhuang Zhen Zhao Ying Xiao Tian Zhuang Xing Zheng Cun 88 Patentee before: Tian Bo |